11
Bioasis Announces Bridge Financing

Bioasis Announces Bridge Financing

5 years ago
Anonymous $9ruWwTnhZq

https://www.businesswire.com/news/home/20191216005622/en/

GUILFORD, Conn.--(BUSINESS WIRE)--Dec 16, 2019--

BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB 3 ™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that it intends to complete a bridge financing transaction (the “Bridge Financing”) for gross proceeds of approximately USD$500,000.

Last Seen
33 minutes ago
Reputation
0
Spam
0.000
Last Seen
12 minutes ago
Reputation
0
Spam
0.000
Last Seen
48 minutes ago
Reputation
0
Spam
0.000
Last Seen
3 hours ago
Reputation
0
Spam
0.000
Last Seen
about an hour ago
Reputation
0
Spam
0.000
Last Seen
a minute ago
Reputation
0
Spam
0.000
Last Seen
about an hour ago
Reputation
0
Spam
0.000
Last Seen
7 minutes ago
Reputation
0
Spam
0.000
Last Seen
a minute ago
Reputation
0
Spam
0.000
Last Seen
about an hour ago
Reputation
0
Spam
0.000
Last Seen
3 hours ago
Reputation
0
Spam
0.000